glp-1 drugs cost with insurance Perspectives from employers on the costs and issues associated covering agonists for weight loss Insurer strategies to control costs
Description
Given existing evidence, triple combination therapy can be expected to provide additional cardiorenal protection, although further randomized controlled trials are needed to determine whether triple combination therapy actually has additive or synergetic effects compared with mono or dual therapy
What the 2025 Expert Consensus Found Using a Delphi process with 58 experts from 17 countries, the panel reviewed available evidence and reached key agreements: 1
These outcomes lead to the remodeling of the extracellular matrix, oxidative stress, inflammation, cardiomyocyte apoptosis, fibrosis, and metabolic abnormalities [55]
Shu X, Zhang Y, Li M, et al
Proper use and lifestyle modification ensure the best results
